Perkins Adelene Q - Insider Non-Derivative Transactions at INFINITY PHARMACEUTICALS, INC. (INFI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 12, 2023, Perkins Adelene Q's relationship to INFINITY PHARMACEUTICALS, INC. (INFI) is Director, and currently has 1,175,291 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other INFI insiders.

Data Source: SEC.
Perkins Adelene Q - Insider Non-Derivative Transactions of INFI Common Stock
Perkins Adelene Q - Insider Non-Derivative Transactions at INFI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 13, 2023 Sell -- (Common Stock) 410196 0.07 1175291
Sep 10, 2023 M -- (Common Stock) 768133 0 1585487